Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-025-04107-6
Affiliations:
5
Authors:
38
Go to article
Institutions Authors Share
KEMRI-Wellcome Trust Research Programme CGMRC, Kenya
23.333333
23.333333
23.333333
 0.61
Oxford The Jenner Institute, United Kingdom (UK)
7.000000
 0.18
Sanaria Inc., United States of America (USA)
6.000000
 0.16
University of Oxford, United Kingdom (UK)
1.666667
 0.04
Interested in Clinical Sciences?